Abstract:Membranous nephropathy (MN) is an organ-restricted autoimmune disease mainly caused by circulating autoantibodies against podocyte antigens, including the M-type phospholipase A2 receptor (PLA2R) and thrombospondin domain-containing 7A (THSD7A). Antibodies against PLA2R are present in 70%–80% and against THSD7A in 2% of adult patients, which provides a paradigm shift in molecular diagnosis and management monitoring. Both antigens share some similar characteristics: they are expressed by podocytes and have wide tissue distributions; they are bound by autoantibodies only under nonreducing conditions, and the subtype of most autoantibodies is IgG4. However, the factors triggering autoantibody production as well as the association among air pollution, malignancy, and the pathogenesis of MN remain unclear. In this review, we discuss the similarity between the pathological mechanisms triggered by disparate antigens and their associated diseases. Furthermore, we demonstrated the possibility that PM2.5, malignancy, and gene expression specifically induce exposure of these antigens through conformational changes, molecular mimicry, or increased expression eliciting autoimmune responses. Thus, this review provides novel insights into the pathological mechanism of MN.

What problem does this paper attempt to address?

This paper attempts to explore the roles and pathological mechanisms of phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A) in membranous nephropathy (MN). Specifically, the paper focuses on the following aspects: 1. **Similar characteristics of PLA2R and THSD7A**: These two antigens are expressed in podocytes and are bound by autoantibodies under non-reducing conditions. Most autoantibody subtypes are IgG4. 2. **Factors triggering autoantibody production**: The paper discusses how air pollution (such as PM2.5), malignancies, and gene expression can induce the exposure of these antigens through conformational changes, molecular mimicry, or increased expression, thereby triggering autoimmune responses. 3. **Structure and epitopes of PLA2R**: Detailed features of PLA2R are introduced, including its N-terminal cysteine-rich region (CysR), fibronectin type 2 (FnII) domain, and C-type lectin-like domains (CTLDs). Studies have found that CysR, CTLD1, and CTLD7 are the main epitopes. 4. **Epitope spreading of PLA2R**: Epitope spreading refers to the phenomenon where the diversity of epitopes recognized by the immune system increases as the disease progresses. This may lead to an enhanced immune response and increased resistance to immunosuppressive therapy. 5. **Structure and epitopes of THSD7A**: The structural features of THSD7A are introduced, including its 21 thrombospondin type-1 domains (TSP-1) and coiled-coil domains. Studies have found that the N-terminal TSR1 domain is the main epitope, recognized by autoantibodies in the serum of 87% of patients. 6. **Pathogenicity of anti-THSD7A antibodies**: Research indicates that anti-THSD7A antibodies can directly affect the integrity of podocytes, leading to proteinuria and podocyte injury without the need for complement system activation. 7. **Extrarenal antigen exposure**: The paper discusses how PM2.5, gene expression, and tumors can promote the exposure of extrarenal antigens, thereby triggering autoimmune responses. Specifically, PM2.5 can cause lung inflammation, releasing extracellular traps from neutrophils and macrophages, which release PLA2R into the systemic circulation, initiating an autoimmune response. 8. **Genetic susceptibility**: The paper explores the genetic susceptibility to PLA2R-associated membranous nephropathy, particularly the interaction between HLA-D and PLA2R1 loci. Specific HLA alleles may increase an individual's susceptibility to PLA2R-associated MN. 9. **Overexpression of THSD7A**: The paper discusses the overexpression of THSD7A in tumors and its relationship with membranous nephropathy. As a tumor-associated antigen, the overexpression of THSD7A may promote autoimmune responses, leading to the occurrence of membranous nephropathy. 10. **Conformational or expression changes of antigens**: Under inflammatory conditions, oxidative stress may lead to the formation of disulfide bonds in proteins, altering the conformation of antigens, thereby affecting their antigenicity and immune response. Overall, this paper provides new insights into the pathological mechanisms of PLA2R and THSD7A in membranous nephropathy, emphasizing the important roles of environmental factors, genetic susceptibility, and conformational changes of antigens in the disease's occurrence.

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy

Membranous Nephropathy: Pathogenesis and Treatments

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role

Quantitative Detection of Anti-Pla2r Antibodies Targeting Different Epitopes and Its Clinical Application in Primary Membranous Nephropathy.

Mechanisms of Primary Membranous Nephropathy

Urine PLA2R Antibody Detection in Hazard Stratification of PLA2R-Associated Membranous Nephropathy.

The Genetic and Environmental Factors of Primary Membranous Nephropathy: an Overview from China

Perspectives in membranous nephropathy

The Application of Podocyte Antigen PLA2R and Anti-Pla2r Antibody in the Diagnosis and Treatment of Membranous Nephropathy

Novel Biomarkers in Membranous Nephropathy

Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy

An Updated Review of Membranous Nephropathy

Membranous nephropathy: Mechanistic insights and therapeutic perspectives

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy

Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China

Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment

Features of Phospholipase A2 Receptor and Thrombospondin Type-1 Domain-Containing 7A in Malignancy-Associated Membranous Nephropathy

Progress on the M-type Phospholipase A2 Receptor in Idiopathic Membranous Nephropathy

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy

C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy